Announcements Trials
Browse Landscape

Status

Completed 537Unknown 277Recruiting 253Terminated 178Not yet recruiting 83Active not recruiting 78Withdrawn 59Enrolling by invitation 6Suspended 3Available 3Approved for marketing 2No longer available 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Expanded_access 3

Sponsor

Cancer Type

CNS 2Other hematologic neoplasm 1Endocrine 1

Conditions

Neoplasms 7Neuroblastoma 4Recurrence 3Prostatic Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive 2Insulinoma 2Immunologic Deficiency Syndromes 2Hypoglycemia 2Hyperinsulinism 2Hematologic Neoplasms 2Typical Teratoid Rhabdoid Tumor 1Triple Negative Local Advanced Breast Cancer 1Thyroid Nodule 1Thalassemia 1Small Cell Lung Carcinoma 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oncology Patients With Gastroparesis 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metabolic Diseases 1Medulloblastoma 1Lymphoma 1

Interventions

3-Iodobenzylguanidine 2Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Available × OTHER × Recurrence × Clear all
NCT04008524 2025-08-06

A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies

Institute of Hematology & Blood Diseases Hospital, China

Available
Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

NCT01370330 2025-07-22

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

University of California, San Francisco

Available
CNS

Neoplasms, Neuroblastoma, Recurrence

NCT03015844 2024-07-05

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

Northwell Health

Available
CNSEndocrine

Neuroblastoma, Pheochromocytoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡